Aug 21 (Reuters) - DJO Inc said the U.S. health regulators approved a supplement, covering new product features, to the existing pre-market approval for the company's bone growth stimulation products.
obstruction of a June 2008 federal audit; charges were recorded in Q1 2011 * Says this final settlement also includes the resolution of a related qui tam category S&P 500 ekes out all-time closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback